Summary
Updated Aug 30, 2026
David N. Watson is Director of AMKOR TECHNOLOGY, INC. (AMKR). 9 SEC Form 4 filings on record going back to 2024, most recently on 25 June 2026.
Recent Transactions
4Every recent SEC Form 4 transaction David N. Watson has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David N. Watson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John T. Kim - $484.90M of AMKR open-market activity in the last 12 months
- 915 Investments, LP - $484.90M of AMKR open-market activity in the last 12 months
- Guillaume Marie Jean Rutten - $9.35M of AMKR open-market activity in the last 12 months
- Mark N. Rogers - $3.05M of AMKR open-market activity in the last 12 months
- Gil C. Tily - $2.09M of AMKR open-market activity in the last 12 months
- Roger Anthony Carolin - $1.52M of AMKR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David N. Watson?
David N. Watson is a corporate insider, tracked as Director of AMKOR TECHNOLOGY, INC. (AMKR). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David N. Watson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of David N. Watson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David N. Watson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial